DOI: https://dx.doi.org/10.18565/therapy.2023.3.61-68
Bochkareva V.O., Demko I.V., Petrova M.M., Obukhova I.A., Kozlov E.V.
1) N.S. Karpovich Krasnoyarsk Interdistrict Clinical Emergency Hospital; 2) Professor V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Healthcare of Russia
1. Уртаева К. К., Сучков В.Н. Случай новой коронавирусной инфекции COVID-19 у пациента, находящегося на лечении программным гемодиализом. Журнал инфектологии. 2020; 12(3): 94–98. [Urtaeva K.K., Suchkov V.N. A case of a new CoVID-19 coronavirus infection in a patient being treated with programmatic hemodialysis. Zhurnal infektologii = Journal Infectology. 2020; 12(3): 94–98 (In Russ.)]. https://dx.doi.org/10.22625/2072-6732-2020-12-3-94-98. EDN: FECRPY. 2. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 16 (18.08.2022). Минздрав России. Доступ: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/060/193/original/BMP_COVID-19_V16.pdf (дата обращения – 01.04.2023). [Interim guidelines «Prevention, diagnosis and treatment of novel coronavirus infection (COVID-19)». Version 16 (08/18/2022). Ministry of Healthcare of Russia. URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/060/193/original/BMP_COVID-19_V16.pdf (date of access – 01.04.2023) (In Russ.)]. 3. SARS-CoV-2 Surveillance Group, Istituto Superiore di Sanità (2020) Characteristics of COVID-19 patients dying in Italy. URL: https://www.epicentro.iss.it/en/coronavirus/sars-cov-2-analysisof-deaths (date of access – 01.04.2023). 4. Portoles J., Marques M., Lopez-Sanchez P. et al. Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak. Nephrol Dial Transplant. 2020; 35(8): 1353–61. https://dx.doi.org/10.1093/ndt/gfaa189. 5. Hassanein M., Radhakrishnan Y., Sedor J. et al. COVID-19 and the kidney. Cleve Clin J Med. 2020; 87(10): 619–31. https://dx.doi.org/10.3949/ccjm.87a.20072. 6. Mohamed M.M., Lukitsch I., Torres-Ortiz A.E. et al. Acute kidney injury associated with coronavirus disease 2019 in urban New Orleans. Kidney360. 2020; 1(7): 614–22. https://dx.doi.org/10.34067/KID.0002652020. 7. Post A., den Deurwaarder E.S.G., Bakker S.J.L. et al. Kidney infarction in patients with COVID-19. Am J Kidney Dis. 2020; 76(3): 431–35. https://dx.doi.org/10.1053/j.ajkd.2020.05.004. 8. Noris M., Benigni A., Remuzzi G. The case of complement activation in COVID-19 multiorgan impact. Kidney Int. 2020; 98(2): 314–22. https://dx.doi.org/10.1016/j.kint.2020.05.013. 9. Cheng Y., Luo R., Wang K. et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020; 97(5): 829–38. https://dx.doi.org/10.1016/j.kint.2020.03.005. 10. Hirsch J.S., Ng J.H., Ross D.W. et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020; 98(1): 209–18. https://dx.doi.org/10.1016/j.kint.2020.05.006. 11. Procaccini F.L., Alcazar Arroyo R., Albalate Ramon M. et al. Acute kidney injury in 3182 patients admitted with COVID-19: a single-center, retrospective, case-control study. Clin Kidney J. 2021; 14(6): 1557–69. https://dx.doi.org/10.1093/ckj/sfab021. 12. Chan L., Chaudhary K., Saha A. et al.; Mount Sinai COVID Informatics Center (MSCIC). AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol. 2021; 32(1): 151–60. https://dx.doi.org/10.1681/ASN.2020050615. 13. Lee J.R., Silberzweig J., Akchurin O. at al. Characteristics of acute kidney injury in hospitalized COVID-19 patients in an urban Academic Medical Center. Clin J Am Soc Nephrol. 2021; 16(2): 284–86. https://dx.doi.org/10.2215/CJN.07440520. 14. Столяревич Е.С., Фролова Н.Ф., Артюхина Л.Ю., Варясин В.В. Поражение почек при Covid-19: клинические и морфологические проявления почечной патологии у 220 пациентов, умерших от Covid-19. Нефрология и диализ. 2020; 22(S): 46–55. [Stolyarevich E.S., Frolova N.F., Artyukhina L.Yu., Varyasin V.V. Kidney damage in Covid-19: clinical and morphological manifestations of renal pathology in 220 patients who died from Covid-19. Nephrologiya i dializ = Nephrology and Dialysis. 2020; 22(S): 46–55 (In Russ.)]. EDN: UIBBVU. 15. Rivero J., Merino-Lopez M., Olmedo R. et al. Association between postmortem kidney biopsy findings and acute kidney injury from patients with SARS-CoV-2 (COVID-19). Clin J Am Soc Nephrol. 2021; 16(5): 685–93. https://dx.doi.org/10.2215/CJN.16281020. 16. Williamson E.J., Walker A.J., Bhaskaran K. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020; 584(7821): 430–36. https://dx.doi.org/10.1038/s41586-020-2521-4. 17. Fernandez-Fresnedo G., Ramos M.A., Gonzalez-Pardo M.C. et al. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant. 2000; 15(4): 502–10. https://dx.doi.org/10.1093/ndt/15.4.502. 18. Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г. с соавт. Регистр «Анализ динамики Коморбидных заболеваний у пациенТов, перенесшИх инфицироВание SARS-CoV-2» (АКТИВ). Оценка влияния комбинаций исходных сопутствующих заболеваний у пациентов с COVID-19 на прогноз. Терапевтический архив. 2022; 94(1): 32–47. [Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G. et al. ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis. Terapevticheskiy arkhiv = Therapeutic Archive. 2022; 94(1): 32–47. https://dx.doi.org/10.26442/00403660.2022.01.201320. EDN: WQMDNC. 19. Basile C., Combe C., Pizzarelli F. et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant. 2020; 35(5): 737–41. https://dx.doi.org/10.1093/ndt/gfaa069. 20. Xu C., Zhang T., Zhu N., Han M. Characteristics of COVID-19 patients with preexisting CKD history. Int Urol Nephrol. 2021; 53(12): 2567–75. https://dx.doi.org/10.1007/s11255-021-02819-5. 21. Coca A., Burballa C., Centellas-Perez F.J. et al. Outcomes of COVID-19 among hospitalized patients with non-dialysis CKD. Front Med (Lausanne). 2020; 7: 615312. https://dx.doi.org/10.3389/fmed.2020.615312. 22. ERA-EDTA Council; ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021; 36(1): 87–94. https://dx.doi.org/10.1093/ndt/gfaa314. 23. Pakhchanian H., Raiker R., Mukherjee A. et al. Outcomes of COVID-19 in CKD patients: A multicenter electronic medical record cohort study. Clin J Am Soc Nephrol. 2021; 16(5): 785–86. https://dx.doi.org/10.2215/CJN.13820820. 24. Orieux A., Rubin S., Prevel R. et al. Severe COVID-19-induced AKI: A 3-month follow-up. Clin Kidney J. 2021; 14(4): 1289–90. https://dx.doi.org/10.1093/ckj/sfab028. 25. Abrishami A., Khalili N., Dalili N. et al. Clinical and radiologic characteristics of COVID-19 in patients with CKD. Iran J Kidney Dis. 2020; 14(4): 267–77. 26. Ozturk S., Turgutalp K., Arici M. et al. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: A nationwide analysis from Turkey. Nephrol Dial Transplant. 2020; 35(12): 2083–95. https://dx.doi.org/10.1093/ndt/gfaa271. 27. Kang S.H., Kim S.W., Kim A.Y. et al. Association between chronic kidney disease or acute kidney injury and clinical outcomes in COVID-19 patients. J Korean Med Sci. 2020; 35(50): e434. https://dx.doi.org/10.3346/jkms.2020.35.e434. 28. Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г. с соавт. Клинические особенности постковидного периода. Результаты международного регистра «Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2 (АКТИВ SARSCoV-2)». Предварительные данные (6 месяцев наблюдения). Российский кардиологический журнал. 2021; 26(10): 86–98. [Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G. et al. Clinical features of post-COVID-19 period. Results of the international register «Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)». Data from 6-month follow-up. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2021; 26(10): 86–98. https://dx.doi.org/10.15829/1560-4071-2021-4708. EDN: ZAPSJL. 29. Khatri M., Charytan D.M., Parnia S. et al. Outcomes among hospitalized chronic kidney disease patients with COVID-19. Kidney360. 2021; 2(7): 1107–14. https://dx.doi.org/10.34067/KID.0006852020. 30. He L., Wei Q., Liu J. et al. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms. Kidney Int. 2017; 92(5): 1071–83. https://dx.doi.org/10.1016/j.kint.2017.06.030. 31. Munblit D., Nekliudov N.A., Bugaeva P. et al.; StopCOVID Research Team. Stop COVID cohort: An observational study of 3480 patients admitted to the Sechenov University Hospital Network in Moscow City for suspected coronavirus disease 2019 (COVID-19) infection. Clin Infect Dis. 2021; 73(1): 1–11. https://dx.doi.org/10.1093/cid/ciaa1535. Erratum in: Clin Infect Dis. 2021 Jun 26. 32. Harrison S.L., Fazio-Eynullayeva E., Lane D.A. et al. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis. PLoS Med. 2020; 17(9): e1003321. https://dx.doi.org/10.1371/journal.pmed.1003321. 33. Henry B.M., Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020; 52(6): 1193–94. https://dx.doi.org/10.1007/s11255-020-02451-9. 34. Patel D.M., Phadke M., Dai F. et al. Association of AKI-D with urinary findings and baseline eGFR in hospitalized COVID-19 patients. Kidney360. 2021; 2(8): 1215–24. https://dx.doi.org/10.34067/KID.0001612021.
Veronika O. Bochkareva, pulmonologist at N.S. Karpovich Krasnoyarsk Interdistrict Clinical Emergency Hospital. Address: 660041, Krasnoyarsk, 17/3 Kurchatova Str. E-mail: bramma-ska@mail.ru
Irina V. Demko, MD, professor, head of the Department of hospital therapy and immunology with a course of professional development, Professor V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Healthcare of Russia. Address: 660022, Krasnoyarsk, 1 Partizana Zheleznyaka Str. E-mail: demko64@mail.ru
Marina M. Petrova, MD, professor, head of the Department of polyclinic therapy and family medicine with a course of professional development, Professor V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Healthcare of Russia. Address: 660022, Krasnoyarsk, 1 Partizana Zheleznyaka Str. E-mail: stk99@yandex.ru
Irina A. Obukhova, pulmonologist at N.S. Karpovich Krasnoyarsk Interdistrict Clinical Emergency Hospital. Address: 660041, Krasnoyarsk, 17/3 Kurchatova Str. E-mail: tolpyga256@gmail.com
Evgeny V. Kozlov, head of the Department of pulmonology, N.S. Karpovich Krasnoyarsk Interdistrict Clinical Emergency Hospital. Address: 660041, Krasnoyarsk, 17/3 Kurchatova Str. E-mail: kev-pulmonolog@mail.ru